ozempic semaglutide weight loss Vs CrossFit Considering a Weight Loss Drug?

Singh, University of Wisconsin-Madison, United States

Unlock this article by subscribing here

Trial results show promising insights into the potential of retatrutide for addressing obesity and various weight-related conditions: In patients with type 2 diabetes (T2D) and obesity, subcutaneous administration of retatrutide for 12 weeks resulted in reductions in body weight of up to 8.96 kg with a safety and tolerability profile similar to other incretins (weight loss peptides)

To verify if your BCBS plan requires prior authorization (PA), contact your plan provider, or check the drug formulary (list of covered drugs) on the BCBS website or your insurance plan documents